• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Kaluril
    / Teva

    Active Ingredient *

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft



    not in the basket chart 11983 11186

    Related information


    Edema: 1-2 tablets a day.
    1 tablet a day as a single dose or in divided doses.
    Do not exceed the maximum dose of 2 tablets a day.


    Edema: Edema associated with congestive cardiac failure, hepatic cirrhosis. Hypertension: As sole therapeutic agent or to enhance effectiveness of other antihypertensive drugs.


    Anuria, severe progressive renal disease, acute renal failure, elevated serum potassium levels, hypersensitivity to any of the components. Not recommended in pregnancy and for children.

    Special Precautions

    Pregnancy and lactation, safety of use in pediatric patients has not been established. Periodic determination of serum electrolytes should be performed. Hyponatremia and hypochloremia may occur. In patients with pre-existing severe liver disease, with renal disease.

    Side Effects

    Headache, weakness, fatigue/tiredness, arrhythmia, nausea/anorexia, diarrhea, gastrointestinal pain, abdominal pain, elevated serum potassium levels, rash, pruritus, leg ache, dizziness, dyspnea. See prescribing information for less common side effects.

    Drug interactions

    Other potassium supplements, potassium-sparing diuretics, ACE inhibitors, triolstane, NSAID’s, lithium. Cardiac glycosides, lithium, insulin, oral hypoglycemics, cholestyramine, colestipol. Acetazolamide, corticosteroids, ACTH, carbenoxolone, indapamide, amphotericin. Antiarrhythmics, estrogens, probenecid, sodium chloride, sodium bicarbonate, NSAIDs. Allopurinol, calcium supplements, laxatives, non-depolarizing muscle relaxants.

    Teva Pharmaceutical Industries Ltd, Israel